Comfirmation of therapeutic drug monitoring for pulmonary hypertension

Comfirmation of therapeutic drug monitoring for pulmonary hypertension - Comfirmation of therapeutic drug monitoring for pulmonary hypertension

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000022593

Enrollment

Registered

2016-06-03

Start date

2016-06-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary hypertension

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients administered sildenafil, tadalafil, bosentan, ambrisentan and/or macitentan

Exclusion criteria

Exclusion criteria: patient who is decided as inadequate by doctor

Design outcomes

Primary

Measure	Time frame
1. plasma drug concentration 2. laboratory tests 3. patients charactoristics 4. drug compliance	—

Countries

Japan

Contacts

Public ContactAkio Hakamata

Hamamatsu University School of Medicine Department of Clinical Pharmacology and Therapeutics

hakamata@hama-med.ac.jp053-435-2385

Outcome results